Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Asimov has raised $175.0M in total funding. The most recent round was Series B. The last funding was announced in January 2023.
Asimov's investors include Andreessen Horowitz, K5 Global, Wing Venture Capital, Pillar VC, Fidelity.
Asimov is headquartered in Boston, United States.
Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.
Asimov is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Asimov — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/asimov. Accessed November 15, 2026.
VCBacked. (2023). Asimov — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/asimov
{{cite web |title=Asimov — Funding & Investors |url=https://www.vcbacked.co/company/asimov |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Asimov? Request a listing update